Mesalazine controlled-release - AbbVie
At a glance
- Drug Originator Procter & Gamble
- Drug Class Aminosalicylic acids; Anti-inflammatories; Antineoplastics; Irritable bowel syndrome therapies; Small molecules
- Mechanism of Action Lipoxygenase-cyclooxygenase inhibitors
- USA Patent Applicants ABBVIE
- USA Patents 6
- NDAs 2
- Patent Applications 8,281
Table of Contents

Disclaimer